Journal Article

Effect of electroencephalography-guided anesthesia on neurocognitive disorders in elderly patients undergoing major non-cardiac surgery: A trial protocol The POEGEA trial (POncd Elderly GEneral Anesthesia)

Carrier, François Martin, Guertin, Marie-Claude, Morisson, Louis, Godbout, Cédric, Verdonck, Olivier, Fortier, Annik, Laferrière-Langlois, Pascal, Fortier, Louis-Philippe, Pagé, Gabrielle, Denault, André, Richebé, Philippe, Ogez, David, Jarry, Stéphanie, Létourneau, Geneviève

2021

Overview

The number of elderly patients undergoing major surgery is rapidly increasing. They are particularly at risk of developing postoperative neurocognitive disorders (NCD). Earlier studies suggested that processed electroencephalographic (EEG) monitors may reduce the incidence of postoperative NCD. However, none of these studies controlled for intraoperative nociception levels or personalized blood pressure targets. Their results remain unclear if the reduction in the incidence of postoperative NCD relates to avoidance of any electroencephalographic pattern suggesting excessive anesthesia depth. The objective of this trial is to investigate-in patients ≥ 70 years old undergoing major non-cardiac surgery-the effect of EEG-guided anesthesia on postoperative NCD while controlling for intraoperative nociception, personalized blood pressure targets, and using detailed information provided by the EEG monitor (including burst suppression ratio, density spectral array, and raw EEG waveform). This prospective, randomized, controlled trial will be conducted in a single Canadian university hospital. Patients ≥ 70 years old undergoing elective major non-cardiac surgery will be included in the trial. The administration of sevoflurane will be adjusted to maintain a BIS index value between 40 and 60, to keep a Suppression Ratio (SR) at 0%, to keep a direct EEG display without any suppression time and a spectrogram with most of the EEG wave frequency within the alpha, theta, and delta frequencies in the EEG-guided group. In the control group, sevoflurane will be administered to achieve an age-adjusted minimum alveolar concentration of [0.8-1.2]. In both groups, a nociception monitor will guide intraoperative opioid administration, individual blood pressure targets will be used, and cerebral oximetry used to tailor intraoperative hemodynamic management. The primary endpoint will be the incidence of NCD at postoperative day 1, as evaluated by the Montreal Cognitive Assessment (MoCA). Secondary endpoints will include the incidence of postoperative NCD at different time points and the evaluation of cognitive trajectories up to 90 days after surgery among EEG-guided and control groups. NCT04825847 on ClinicalTrials.gov.

• Publisher: Public Library of Science,Public Library of Science (PLoS)
• Subject: Aged / Alveoli / Anesthesia / Anesthesia, General - adverse effects / Anesthesiology / Anesthetics, Inhalation - administration & dosage / Biology and Life Sciences / Blood Pressure / Cognition / Cognitive ability / Cognitive impairment / Complications and side effects / Customization / Degeneration / Delirium / Disorders / Drug dosages / EEG / Elective Surgical Procedures / Electroencephalography / Evaluation / General anesthesia / Health aspects / Health risks / Heart / Heart surgery / Hemodynamics / Hospitals / Humans / Hypotension / Medicine / Medicine and Health Sciences / Nervous system / Neurocognitive Disorders - etiology / Older people / Opioids / Oximetry / Pain / Pain perception / Patient outcomes / Patients / Postoperative Complications / Prospective Studies / Randomized Controlled Trials as Topic / Research and Analysis Methods / Sevoflurane / Sevoflurane - administration & dosage / Study Protocol / Surgery / Theta rhythms / Trajectory analysis / Values / Waveforms